ena-STUDY-SAN DIEGO STATE UNIV-13-10-2020-21:28:45:052-141
Alterations in gut microbiota do not play a causal role in diet-independent weight gain caused by ovariectomy
Estrogen deficiency in post-menopausal women is associated with metabolic dysregulation including weight gain, increased adiposity, and insulin resistance. Ovariectomized (OVX) rodent models, often combined with a high-fat diet (HFD), have been used to investigate the effects of decreased estrogen production on metabolism. Since evidence suggests that gut microbes may facilitate the protective effect of estrogen on metabolic dysregulation in an OVX+HFD model, we investigated whether the gut microbiome plays a role in the diet-independent weight gain that occurs after OVX in adult female mice. 16S rRNA gene sequence analysis demonstrated that OVX was not associated with changes in overall gut bacterial biodiversity but was correlated with a shift in beta diversity. Using differential abundance analysis, we observed a difference in the relative abundance of a few bacterial taxa such as Turicibacter 3-5 weeks after OVX which was subsequent to the weight gain that occurred 2 weeks post-surgery. A cohousing study was performed to determine whether exposure to a healthy gut microbiome was protective against the development of the metabolic phenotype associated with OVX. Unlike mouse models of obesity, HFD maternal-induced metabolic dysregulation or polycystic ovary syndrome, cohousing OVX mice with healthy mice did not improve the metabolic phenotype of OVX mice. Altogether, these results indicate changes in the gut microbiome are unlikely to play a causal role in diet-independent, OVX-induced weight gain since they occur after the weight gain and cohousing with healthy mice was not protective against the weight gain.
Estrogen deficiency in post-menopausal women is associated with metabolic dysregulation including weight gain, increased adiposity, and insulin resistance. Ovariectomized (OVX) rodent models, often combined with a high-fat diet (HFD), have been used to investigate the effects of decreased estrogen production on metabolism. Since evidence suggests that gut microbes may facilitate the protective effect of estrogen on metabolic dysregulation in an OVX+HFD model, we investigated whether the gut microbiome plays a role in the diet-independent weight gain that occurs after OVX in adult female mice. 16S rRNA gene sequence analysis demonstrated that OVX was not associated with changes in overall gut bacterial biodiversity but was correlated with a shift in beta diversity. Using differential abundance analysis, we observed a difference in the relative abundance of a few bacterial taxa such as Turicibacter 3-5 weeks after OVX which was subsequent to the weight gain that occurred 2 weeks post-surgery. A cohousing study was performed to determine whether exposure to a healthy gut microbiome was protective against the development of the metabolic phenotype associated with OVX. Unlike mouse models of obesity, HFD maternal-induced metabolic dysregulation or polycystic ovary syndrome, cohousing OVX mice with healthy mice did not improve the metabolic phenotype of OVX mice. Altogether, these results indicate changes in the gut microbiome are unlikely to play a causal role in diet-independent, OVX-induced weight gain since they occur after the weight gain and cohousing with healthy mice was not protective against the weight gain.